| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Chengdu huasun technology group Inc. , LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.43 |
| 52 Week High | CN¥5.87 |
| 52 Week Low | CN¥3.02 |
| Beta | 0.13 |
| 11 Month Change | 0.88% |
| 3 Month Change | -11.83% |
| 1 Year Change | -27.33% |
| 33 Year Change | -36.01% |
| 5 Year Change | -22.92% |
| Change since IPO | -48.23% |
Recent News & Updates
Shareholder Returns
| 000790 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.7% | -2.4% | -1.6% |
| 1Y | -27.3% | -9.3% | -18.6% |
Return vs Industry: 000790 underperformed the CN Pharmaceuticals industry which returned -9.3% over the past year.
Return vs Market: 000790 underperformed the CN Market which returned -18.6% over the past year.
Price Volatility
| 000790 volatility | |
|---|---|
| 000790 Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 000790's share price has been volatile over the past 3 months.
Volatility Over Time: 000790's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 857 | Mingliang Huang | www.huasungrp.com |
Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs.
Chengdu huasun technology group Inc. , LTD. Fundamentals Summary
| 000790 fundamental statistics | |
|---|---|
| Market cap | CN¥2.14b |
| Earnings (TTM) | CN¥21.98m |
| Revenue (TTM) | CN¥978.16m |
97.3x
P/E Ratio2.2x
P/S RatioIs 000790 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000790 income statement (TTM) | |
|---|---|
| Revenue | CN¥978.16m |
| Cost of Revenue | CN¥530.77m |
| Gross Profit | CN¥447.39m |
| Other Expenses | CN¥425.41m |
| Earnings | CN¥21.98m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.035 |
| Gross Margin | 45.74% |
| Net Profit Margin | 2.25% |
| Debt/Equity Ratio | 38.5% |
How did 000790 perform over the long term?
See historical performance and comparison